The Aftermath of a 'Miracle Cure' for a Rare Cancer
By James Tabery,
Wired
| 09. 04. 2023
You really can't understand all the excitement surrounding personalized medicine without knowing a little bit about Gleevec. And once you know the full story of Gleevec, you really can’t help but see much of that excitement as wild and even dangerous exaggeration.
Personalized medicine (sometimes it’s also called “precision medicine”) works by tailoring health care to our genomes. Traditional, one-size-fits-all medicine, the criticism goes, treats us all as if we’re the same, but personalized medicine tracks the molecular-genetic differences between us to deliver the right treatment, to the right patient, at the right time. The approach has gotten its most purchase in the management of cancers and rare diseases, but champions foresee a future where it spreads out across all facets of health care, revolutionizing the treatment of everything from diabetes and cardiovascular disease to asthma and rheumatoid arthritis. A big part of the enthusiasm is economic in nature. Rather than sending patients off on costly and frustrating trial-and-error odysseys, advocates of precision medicine see its ability to find the right gene-treatment matches from the beginning of care...
Related Articles
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Katrina Miller, The New York TImes | 02.05.2026
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal jurisdiction of an American Indian nation, on the Cheyenne River Sioux Reservation in Eagle Butte, S.D.
NativeBio participated in a ...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Lauren Hammer Breslow and Vanessa Smith, Bill of Health | 01.28.2026
On Jan. 24, 2026, the New York Times reported that DNA sequences contributed by children and families to support a federal effort to understand adolescent brain development were later co-opted by other researchers and used to publish “race science”...